Our Commitment to Study Participants
IMA Clinical Research is committed to quality and excellence in our service of our clinical trial participants. The clinical trial process is necessary for medicines, devices, and other therapies to be approved by the Federal Drug Administration (FDA) and made available for the public. Participation in a clinical trial is always voluntary and is a personal decision.
Your Important Role
Each and every participant in a clinical trial plays an essential role in the advancement of medicine. A clinical trial may seek to cure or ease the lives of patients with chronic illnesses, innovate better treatment options than those currently available, develop new technologies that may one day be the hallmark of treatment, or improve overall quality of life for patients, among others. Being a part of this process means you are part of the reason why a better therapy may soon exist for not only yourself, but future generations to come.
How do I participate?
Clinical trial participation is completely voluntary and you must sign a consent form to participate. Participation can involve both risks and benefits. The risks and benefits of participation will discussed with you in detail prior to your decision to participate. You will have the opportunity to ask questions and receive compassionate care from our experienced staff, including physician investigators, nurse practitioners, physician assistants, nurses, coordinators, medical assistants and lab technicians.
Thank you for your consideration in becoming a clinical trial participant and an essential member of the team it takes to aid health care officials in advancing medical knowledge and finding new, preferred treatment options for patients everywhere. Please contact us with any further questions or concerns, we look forward to hearing from you!
Ready to sign up? Fill out the fields below and press submit:
Oversight and Best Practices
Participant health and safety is the primary priority in our clinical research trials. An independent committee called an Institutional Review Board (IRB) protects the rights and welfare of participants involved in our clinical trials and ensures clinical trials are held to the highest ethical standards.
The FDA and Global International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use Good Clinical Practices (ICH-GCP) are organizations that set guidelines for the safety of patients during clinical trials. For further information on this topic, please visit https://www.fda.gov/AboutFDA/WhatWeDo/default.htm